Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
Biochemical Pharmacology|January 16, 1999
Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophagesC Centemeri, S Colli, D Tosarello, et al.
Lipids|September 1, 1985
Oral polyunsaturated phosphatidylcholine reduces platelet lipid and cholesterol contents in healthy volunteersC Galli, E Tremoli, E Giani, et al.
Atherosclerosis|January 1, 1990
Evaluation of atherosclerotic lesions using NMR microimagingM Asdente, L Pavesi, P L Oreste, et al.
European Journal of Clinical Pharmacology|June 12, 1979
Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to manV Tamassia, G Corvi, L M Fuccella, et al.
Biochemical Pharmacology|August 18, 1992
In human monocytes interleukin-1 stimulates a phospholipase C active on phosphatidylcholine and inactive on phosphatidylinositolG Galella, L Medini, E Stragliotto, et al.
Stroke|August 1, 1994
Common carotid intima-media thickness measurement. A method to improve accuracy and precisionD Baldassarre, J P Werba, E Tremoli, et al.
Pharmacological Research Communications|June 1, 1986
Cardiovascular and pulmonary activity of platelet-activating factor (PAF-acether) and its derivativesF Berti, V Ferri, M Pallavicini, et al.
Neurotoxicology|June 1, 2005
Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemiaM Cimino, W Balduini, S Carloni, et al.
Stroke|March 1, 1996
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial diseaseM Cortellaro, D Baldassarre, E Cofrancesco, et al.
Atherosclerosis|April 1, 1986
Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjectsA R Eynard, E Tremoli, D Caruso, et al.
Pageof 21